The Board of Directors approved the consolidated financial statements for the fiscal year ended 31 December 2025.
The disclosure of the endorsed financial statements is deferred pending final regulatory approval of the financials for the company's operating subsidiaries.
The Annual General Meeting (AGM) is scheduled to be held on Friday, 24 April 2026, subject to receiving all necessary regulatory approvals.